Bayhealth Medical Center, INC.

Bayhealth Medical Center, INC. was paid $79.32M by Medicaid between Jan 2018 and Dec 2024, across 407 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	535,071	$5.85M
2019	410,817	$11.91M
2020	268,487	$24.68M
2021	124,744	$8.65M
2022	207,737	$9.97M
2023	173,366	$11.09M
2024incomplete	86,169	$7.16M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	11%	53,926	40,911	$9.11M
99281	Emergency department visit for the evaluation and management, self-limited or minor	6.6%	32,584	25,297	$5.24M
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.5%	29,365	23,169	$5.16M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.2%	26,360	19,007	$4.91M
G0378	Hospital observation service, per hour	5.7%	22,854	8,364	$4.53M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.7%	8,772	6,511	$2.93M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.2%	17,126	11,194	$2.53M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.2%	116,585	74,908	$1.77M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.2%	40,413	27,790	$1.77M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.2%	27,571	17,638	$1.72M
70450	Computed tomography, head or brain; without contrast material	1.9%	12,008	8,588	$1.49M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.6%	2,747	2,306	$1.28M

395 more codes

96375	Therapeutic injection; each additional sequential IV push	1.5%	18,806	$1.17M
71045	Radiologic examination, chest; single view	1.4%	35,743	$1.14M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.4%	27,142	$1.13M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.4%	1,764	$1.10M
80053	Comprehensive metabolic panel	1.4%	89,187	$1.07M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.3%	4,609	$1.03M
0240U		1.2%	9,539	$981K
76819	Fetal biophysical profile; without non-stress testing	1.2%	25,874	$937K
71275	Computed tomographic angiography, chest, with contrast material	1.0%	2,767	$795K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	8,120	$784K
96361	Intravenous infusion, hydration; each additional hour	<1%	11,658	$763K
36415	Collection of venous blood by venipuncture	<1%	148,928	$743K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	14,471	$731K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	14,425	$681K
93975		<1%	3,276	$664K
59025	Fetal non-stress test	<1%	4,227	$618K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	14,131	$605K
84484		<1%	28,976	$549K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,755	$530K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,593	$510K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,001	$500K
93976		<1%	2,604	$490K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	5,820	$473K
81001		<1%	47,368	$413K
87486		<1%	2,486	$406K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	6,755	$397K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,096	$383K
83690		<1%	20,349	$380K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,999	$373K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	5,717	$364K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,362	$351K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	8,724	$347K
99213	Doctor's office visit, returning patient (routine)	<1%	10,605	$346K
99214	Doctor's office visit, returning patient (more involved)	<1%	6,231	$343K
87631		<1%	2,367	$329K
83735		<1%	39,012	$311K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	3,633	$301K
80050	General health panel	<1%	5,948	$288K
84703		<1%	10,673	$269K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,036	$265K
90792	Psychiatric diagnostic evaluation with medical services	<1%	2,418	$236K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,518	$232K
93971		<1%	1,810	$228K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,210	$222K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	8,648	$221K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	628	$208K
80048	Basic metabolic panel (calcium, ionized)	<1%	31,051	$206K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,757	$191K
80061	Lipid panel	<1%	15,154	$189K
93970		<1%	978	$182K
76821		<1%	5,384	$181K
71046	Radiologic examination, chest; 2 views	<1%	12,783	$180K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,262	$177K
70486		<1%	1,141	$172K
82550		<1%	22,775	$171K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,805	$170K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,117	$168K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,667	$167K
76801		<1%	3,974	$166K
76830	Ultrasound, transvaginal	<1%	2,737	$164K
78815	Positron emission tomography (PET) for limited area imaging	<1%	282	$162K
71250		<1%	1,653	$153K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,433	$150K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,581	$150K
93458		<1%	47	$149K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,481	$145K
81025		<1%	10,462	$138K
84443	Thyroid stimulating hormone (TSH)	<1%	9,144	$137K
85730		<1%	19,343	$136K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,581	$133K
76820		<1%	6,950	$129K
96376		<1%	2,667	$127K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	8,563	$127K
84439		<1%	6,356	$126K
11045		<1%	58	$119K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,421	$116K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	911	$116K
99204	Doctor's office visit, new patient (more involved)	<1%	1,637	$114K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,170	$112K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	275	$112K
87581		<1%	2,486	$110K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,333	$104K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,572	$102K
87040		<1%	4,560	$101K
73564		<1%	4,717	$101K
41899	Unlisted procedure, dentoalveolar structures	<1%	98	$100K
93017		<1%	510	$100K
99203	Doctor's office visit, new patient (routine)	<1%	1,875	$100K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	342	$99K
99222	Initial hospital care, per day, moderate complexity	<1%	1,879	$93K
84702		<1%	3,417	$88K
83880		<1%	3,406	$88K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	334	$84K
J3490	Unclassified drugs	<1%	12,772	$83K
94664		<1%	3,497	$80K
85027		<1%	12,677	$80K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	598	$80K
87070		<1%	5,069	$77K
85610		<1%	23,057	$77K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,382	$77K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	160	$73K
76642		<1%	2,470	$73K
97161		<1%	2,193	$72K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,629	$69K
J2704	Injection, propofol, 10 mg	<1%	11,017	$66K
94762		<1%	996	$64K
82553		<1%	6,701	$64K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	5,946	$64K
73130		<1%	3,094	$63K
82728		<1%	4,161	$63K
87507		<1%	311	$62K
J1756	Injection, iron sucrose, 1 mg	<1%	668	$62K
82962		<1%	22,594	$62K
C1769	Guide wire	<1%	1,004	$62K
73030		<1%	3,322	$61K
73610		<1%	2,877	$59K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,947	$55K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,326	$55K
73630		<1%	2,881	$54K
96367		<1%	932	$53K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	1,269	$53K
84466		<1%	3,037	$51K
83605		<1%	5,224	$50K
85379		<1%	2,500	$50K
86850		<1%	4,890	$49K
77065	Tomosynthesis, mammo	<1%	1,116	$48K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,874	$48K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,670	$47K
82607		<1%	2,361	$47K
76770		<1%	1,019	$46K
86901		<1%	6,134	$45K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	327	$45K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,740	$45K
97165		<1%	1,686	$45K
83540		<1%	3,880	$43K
99221		<1%	1,158	$43K
88304		<1%	1,660	$42K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	202	$41K
93880		<1%	263	$40K
83655		<1%	1,725	$39K
76536		<1%	949	$39K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	15,228	$39K
86140		<1%	4,950	$38K
99223	Prolong inpt eval add15 m	<1%	544	$37K
77066	Tomosynthesis, mammo	<1%	652	$37K
94760		<1%	3,358	$37K
90715		<1%	1,708	$36K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,438	$36K
73110		<1%	2,025	$36K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,602	$36K
88307		<1%	1,173	$35K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	428	$35K
86900		<1%	5,107	$35K
99232	Hospital visit by a doctor, follow-up day	<1%	1,155	$35K
77336		<1%	603	$34K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,481	$32K
87186		<1%	3,262	$31K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	773	$30K
82746		<1%	1,426	$30K
87077		<1%	3,642	$28K
73140		<1%	1,090	$28K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	727	$27K
J2785	Injection, regadenoson, 0.1 mg	<1%	242	$27K
82570		<1%	3,885	$27K
J1453	Injection, fosaprepitant, 1 mg	<1%	116	$27K
82043		<1%	2,473	$27K
36591		<1%	2,336	$26K
97010		<1%	1,861	$26K
72100		<1%	1,608	$25K
83874		<1%	4,680	$25K
88342		<1%	855	$25K
87522	Neg quan hep c or qual rna	<1%	439	$24K
84100		<1%	5,118	$24K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	352	$24K
88341		<1%	342	$23K
80076		<1%	3,138	$23K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,003	$23K
J1644	Injection, heparin sodium, per 1000 units	<1%	10,487	$23K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	596	$23K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	387	$23K
76813		<1%	563	$22K
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	<1%	173	$22K
96415		<1%	103	$22K
97116		<1%	996	$22K
84112		<1%	274	$21K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,121	$21K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,440	$20K
12001		<1%	343	$19K
97597		<1%	477	$19K
82150		<1%	2,758	$19K
74018		<1%	1,530	$19K
84436		<1%	2,667	$19K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	240	$18K
85652		<1%	4,725	$18K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,869	$18K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,573	$18K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,250	$18K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	317	$18K
73502		<1%	1,395	$18K
72110		<1%	1,169	$18K
96417		<1%	90	$18K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,080	$17K
97162		<1%	351	$17K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,770	$17K
86803		<1%	961	$17K
99215	Doctor's office visit, returning patient (complex)	<1%	173	$15K
84479		<1%	1,801	$15K
87210		<1%	2,220	$15K
73080		<1%	871	$15K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,808	$15K
84550		<1%	1,998	$14K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,144	$14K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,572	$14K
87205		<1%	2,005	$14K
10060		<1%	395	$13K
00731		<1%	278	$13K
73590		<1%	724	$13K
80074		<1%	362	$13K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	522	$13K
84460		<1%	1,377	$13K
36430		<1%	210	$13K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,248	$13K
70544		<1%	49	$13K
86038		<1%	772	$12K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	13,382	$12K
84450		<1%	1,235	$12K
84156		<1%	1,706	$12K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	22,349	$12K
80069		<1%	1,868	$11K
76870		<1%	220	$11K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	91	$10K
J3370	Injection, vancomycin hcl, 500 mg	<1%	508	$10K
82803		<1%	748	$10K
82248		<1%	1,064	$10K
86618		<1%	344	$10K
82565		<1%	1,412	$10K
72040		<1%	684	$10K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	468	$10K
73090		<1%	582	$10K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	102	$10K
74022		<1%	648	$9K
80143		<1%	645	$9K
84520		<1%	1,374	$9K
94799		<1%	1,129	$9K
96523		<1%	604	$9K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	290	$9K
86780		<1%	399	$9K
86617		<1%	204	$9K
80179		<1%	586	$9K
84403		<1%	226	$9K
97113		<1%	105	$9K
82247		<1%	747	$8K
83970		<1%	388	$8K
72050		<1%	479	$8K
94060		<1%	49	$8K
76827		<1%	222	$8K
29125		<1%	114	$8K
J3411	Injection, thiamine hcl, 100 mg	<1%	966	$7K
87147		<1%	987	$7K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,181	$7K
87340		<1%	717	$7K
71101		<1%	473	$7K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	15	$7K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	79	$7K
76942		<1%	58	$7K
70491		<1%	169	$7K
C1760	Closure device, vascular (implantable/insertable)	<1%	43	$6K
72072		<1%	588	$6K
86592		<1%	653	$6K
73560		<1%	344	$6K
86923		<1%	106	$6K
90686		<1%	411	$6K
01961		<1%	70	$6K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	872	$6K
29505		<1%	56	$6K
12011		<1%	134	$5K
83615		<1%	593	$5K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	347	$5K
82009		<1%	1,027	$5K
83883		<1%	181	$5K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	8,455	$5K
97802		<1%	76	$4K
J1953	Injection, levetiracetam, 10 mg	<1%	267	$4K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	49	$4K
93925		<1%	31	$4K
84153		<1%	223	$4K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,870	$4K
73221		<1%	84	$4K
86665		<1%	86	$4K
J1940	Injection, furosemide, up to 20 mg	<1%	316	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	366	$4K
84480		<1%	317	$4K
80164		<1%	421	$4K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	74	$3K
99205	Prolong outpt/office vis	<1%	28	$3K
99442		<1%	58	$3K
83516		<1%	119	$3K
J2060	Injection, lorazepam, 2 mg	<1%	2,631	$3K
73060		<1%	150	$3K
86308		<1%	311	$3K
36600		<1%	292	$3K
0002A		<1%	134	$3K
G0416	Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method	<1%	15	$3K
96411		<1%	26	$3K
85018		<1%	910	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,474	$2K
87493		<1%	169	$2K
82977		<1%	205	$2K
82533		<1%	77	$2K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	277	$2K
82784		<1%	98	$2K
86431		<1%	481	$2K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,646	$2K
0001A		<1%	167	$2K
85014		<1%	840	$2K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	348	$2K
J1956	Injection, levofloxacin, 250 mg	<1%	233	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,615	$2K
73552		<1%	167	$2K
00840		<1%	28	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	34	$2K
82272		<1%	362	$2K
74183		<1%	35	$1K
81003		<1%	236	$1K
J1630	Injection, haloperidol, up to 5 mg	<1%	116	$1K
86664		<1%	64	$1K
J0456	Injection, azithromycin, 500 mg	<1%	120	$1K
76818		<1%	74	$1K
29515		<1%	13	$1K
99219		<1%	14	$1K
85007		<1%	410	$1K
96368		<1%	15	$1K
70498		<1%	13	$1K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	169	$1K
97535	Self-care/home management training, each 15 minutes	<1%	89	$1K
72141		<1%	49	$1K
12002		<1%	88	$1K
84146		<1%	33	$1K
77427		<1%	85	$935.84
83010		<1%	45	$916.43
85045		<1%	383	$914.27
88173		<1%	70	$887.28
99441		<1%	31	$860.52
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	65	$846.62
94729		<1%	15	$777.75
0012A		<1%	135	$742.30
84145		<1%	56	$725.70
86376		<1%	91	$725.70
77080		<1%	32	$724.30
80177		<1%	81	$721.66
0011A		<1%	120	$696.65
86003		<1%	32	$600.48
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	50	$596.53
70360		<1%	31	$583.62
99356		<1%	40	$581.89
C1753	Catheter, intravascular ultrasound	<1%	170	$524.44
84165		<1%	117	$464.35
73562		<1%	353	$458.67
84155		<1%	131	$396.35
J7510	Prednisolone oral, per 5 mg	<1%	513	$386.16
73522		<1%	28	$375.61
82270		<1%	501	$360.05
99358	Prolong nursin fac eval 15m	<1%	12	$356.37
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	33	$356.30
73100		<1%	37	$348.38
82140		<1%	15	$348.13
19083		<1%	16	$293.44
76882		<1%	60	$246.66
80178		<1%	16	$234.63
88302		<1%	124	$176.66
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	18	$161.78
84132		<1%	38	$149.94
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	50	$140.11
85347		<1%	16	$117.67
86225		<1%	14	$115.82
82785		<1%	46	$100.46
83001		<1%	12	$94.50
86762		<1%	19	$82.56
90714		<1%	18	$49.78
72170		<1%	16	$36.29
G0008	Administration of influenza virus vaccine	<1%	97	$29.46
93016		<1%	47	$25.02
89051		<1%	14	$19.59
86317		<1%	15	$17.66
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	17,898	$10.45
88108		<1%	22	$9.49
88311		<1%	23	$5.26
91301		<1%	48	$0.43
91300		<1%	133	$0.34
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	295	$0.02
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	348	$0.02
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	47	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	47	$0.00
73660		0%	17	$0.00
86160		0%	27	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMURPHY, TERRY (PRESIDENT-CEO)